Document is current
Any future updates will be listed below
-
Authors
El-Mallakh, Rif S.
Gao, Yonglin
You, Pan
- License Information
-
More Information
Article History
Received: 24 June 2020
Accepted: 17 November 2020
First Online: 1 February 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Dr. El-Mallakh is on the speakers’ bureau of Alkermes, Indivior, Intra-Cellular Therapeutics, Janssen, Lundbeck, Otsuka, Sunovion, and Teva. The other authors do not have any conflicts of interests to declare.
